Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2013 05/21/2013 05/22/2013 05/23/2013 05/24/2013 Date
263.64(c) 259.96(c) 262.42(c) 254.87(c) 250.31(c) Last
536 285 804 876 1 060 364 855 134 667 138 Volume
-1.25% -1.40% +0.95% -2.88% -1.79% Change
More quotes
Company
Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows: - sales of products (62.2%); - supply of collaborative services (35.8%): working with the... 
Read more
Sector
Biotechnology
Calendar
05/29 | 08:40amPresentation
Surperformance© rating of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More about the company
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 1 948 M
EBIT 2013 704 M
Net income 2013 454 M
Finance 2013 881 M
Yield 2013 -
Sales 2014 2 476 M
EBIT 2014 1 109 M
Net income 2014 687 M
Finance 2014 1 986 M
Yield 2014 -
PER 2013 62,37
PER 2014 42,81
EV / Sales 2013 12,1x
EV / Sales 2014 9,10x
Capitalization 24 522 M
More Financials
Latest news on REGENERON PHARMACEUTICALS
4d agoDJRegeneron-Sanofi Asthma Drug Shows Promising Early Results
4d ago REGENERON PHARMACEUTICALS INC: Sanofi and Regeneron Announce Publication of Pos..
05/15 REGENERON PHARMACEUTICALS INC: Sanofi and Regeneron Announce Patient Enrollment..
05/08 REGENERON PHARMACEUTICALS INC: Regeneron Announces Upcoming 2013 Investor Confe..
05/03 REGENERON PHARMACEUTICALS INC: Regeneron Acquires Full Rights to Two Novel Opht..
05/01DJAllergan Reports Drug Development Delay, Lower Profits
05/01DJAllergan Reports Drug Development Delay, Lower Profits
04/29DJRegeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation
04/25DJU.S. HOT STOCK FUTURES: Hot stocks to watch
04/25DJU.S. HOT STOCK FUTURES: Hot stocks to watch
04/24DJRegeneron to Join S&P 500 After MetroPCS Merger with T-Mobile
04/18 REGENERON PHARMACEUTICALS INC: Regeneron Announces Upcoming 2013 Investor Confe..
More news
Forum REGENERON PHARMACEUTICALS
Be the first to post a message on REGENERON PHARMACEUTICALS
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Regeneron Pharmaceuticals : Income Statement Evolution
More Financials
EPS Revisions
Regeneron Pharmaceuticals : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.